TCL Archive In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges October 3, 1980
TCL Archive NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification April 10, 1981
TCL Archive Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin July 23, 2010